FindTrial
Sign In

A comparison of incidences of vertebral fracture in Japanese patients with osteoporosis treated with Etidronate and alfacalcidol; a randomized, double-blind study

A comparison of incidences of vertebral fracture in Japanese patients with osteoporosis treated with Etidronate and alfacalcidol; a randomized, double-blind study

Status
Unknown
Phases
Phase 4
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT1080220091
Enrollment
Unknown
Registered
2005-09-12
Start date
2005-09-12
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary osteoporosis

Interventions

investigational material(s) Generic name etc : EHDP (Etidronate Disodium) INN of investigational material : Therapeutic category code : 399 Agents affecting metabolism, n.e.c. Dosage and Administrati

Sponsors

Dainippon Sumitomo Pharma Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: -Primary osteoporosis -Patient who had none or one to four vertebral (T4-L5) fracture(s) -Menopausal or postmenopausal woman or man aged 50 to less than 77 -Patients who can walk (hospitalization/outpatient) etc. -Secondary osteoporosis -Other diseases with reduced bone mass except secondary osteoporosis -Radiographic finding that might affect the vertebral intensity etc.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Efficacy: Incidences of vertebral fracture, etc.—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026